Ethics, communication and palliative care in the ICU: breaking bad news (SPIKES), family meetings and shared decisions, Indian law on withholding and withdrawing treatment (Common Cause 2018/2023), palliative symptom care and compassionate extubation, the organ donation request, and documentation and medico-legal practice.
6 topics
- 01
Breaking bad news (SPIKES)
A six-step structure for giving serious news to patients and families in the ICU, with language that works in Indian settings.
6 stepsNew - 02
Family meetings and shared decision-making
Running a structured family conference (VALUE), handling disagreement and potentially inappropriate treatment requests.
7 stepsAlgorithmNew - 03
Withholding and withdrawing treatment in India (law and process)
The legal basis after Common Cause 2018 and the 2023 modification, DNAR, the two-medical-board process and ISCCM guidance.
7 stepsAlgorithmNew - 04
Palliative symptom care and compassionate extubation
Comfort-focused care at the end of life: pain, breathlessness, agitation and secretions, and how to withdraw ventilation humanely.
7 steps4 dosesNew - 05
Organ donation: the request conversation
Identifying potential donors, the mandated request in India, decoupling the request from news of death, and working with transplant coordinators.
6 stepsNew - 06
Consent, capacity, documentation and medico-legal practice
Informed consent in ICU, capacity and surrogate decisions, medico-legal cases, records, and LAMA/DAMA discharge.
6 stepsNew
Drugs in this module
Doses written for this module's context. The same drug may read differently in another module.
Morphine
Opioid analgesic
Morphine
Opioid analgesic
- Indications
- Pain and breathlessness at the end of life
- Adult dose
- Opioid-naive: 1-2 mg IV or 2.5-5 mg SC as needed (every 1-2 h); infusion 0.5-2 mg/h IV/SC titrated to comfort. Patients already on opioids: continue and increase by 25-50% for uncontrolled symptoms.
- Preparation (India)
- 10 mg/mL and 15 mg/mL ampoules (NDPS licensing required; availability restricted in some hospitals).
- Renal / hepatic
- Active metabolites accumulate in AKI/CKD - use smaller doses, longer intervals or fentanyl.
- Cautions
- Titrate to symptoms, not to a time of death; document intent (comfort).
Midazolam
Benzodiazepine
Midazolam
Benzodiazepine
- Indications
- Anxiety, distress, agitation and palliative sedation at the end of life; seizures
- Adult dose
- 1-2 mg IV or 2.5-5 mg SC as needed; infusion 0.5-2 mg/h IV/SC titrated to comfort.
- Preparation (India)
- 1 mg/mL and 5 mg/mL ampoules.
- Renal / hepatic
- Accumulates in renal and hepatic failure.
- Cautions
- Combine with opioid for distressing breathlessness only when anxiety is prominent.
Glycopyrronium (glycopyrrolate)
Antimuscarinic (does not cross blood-brain barrier)
Glycopyrronium (glycopyrrolate)
Antimuscarinic (does not cross blood-brain barrier)
- Indications
- Noisy respiratory secretions ('death rattle')
- Adult dose
- 200 mcg SC/IV every 4-6 h as needed (maximum about 1.2 mg/24 h).
- Preparation (India)
- 0.2 mg/mL ampoules.
- Cautions
- Dry mouth, urinary retention; best given early; reassure families that the noise is rarely distressing to the patient.
Hyoscine butylbromide
Antimuscarinic
Hyoscine butylbromide
Antimuscarinic
- Indications
- Noisy respiratory secretions; colic
- Adult dose
- 20 mg SC/IV every 4 h as needed (maximum 120 mg/24 h).
- Preparation (India)
- 20 mg/mL ampoules (widely available in India).
- Cautions
- Tachycardia, dry mouth, urinary retention.

